SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-018442
Filing Date
2024-06-28
Accepted
2024-06-28 16:30:48
Documents
1
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 form4-06282024_040643.html 4  
1 form4-06282024_040643.xml 4 6095
  Complete submission text file 0001415889-24-018442.txt   7595
Mailing Address C/O LUMENA PHARMACEUTICALS, INC. 12531 HIGH BLUFF DRIVE, SUITE 110 SAN DIEGO CA 92130
Business Address
McNulty Alana B. (Reporting) CIK: 0001606086 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 241086193

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)